Septerna, Inc.
SEPNNasdaqCIK 1984086HealthcareFiscal year ends Dec 31
Reports and events: 41 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-2512:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-364210 |
| 2026-08-1421:14 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001346824-26-000228 |
| 2026-08-1020:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-342353 |
| 2026-08-1020:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342328 |
| 2026-06-3020:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-290649 |
| 2026-05-1120:08 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-216759 |
| 2026-05-1120:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-216723 |
| 2026-04-3020:21 ET | DEF 14A | Proxy statementPeriod 2026-04-30 | 0001193125-26-197404 |
| 2026-04-1312:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-152045 |
| 2026-03-0920:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-098507 |
| 2026-03-0920:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-098489 |
| 2026-03-0212:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-084142 |
| 2026-01-1213:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009864 |
| 2026-01-0821:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-007772 |
| 2025-11-1013:44 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-273375 |
| 2025-11-1013:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-273373 |
| 2025-09-2920:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-223292 |
| 2025-09-0311:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-194472 |
| 2025-08-2112:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-184706 |
| 2025-08-1120:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106551 |
| 2025-08-1120:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106540 |
| 2025-08-0420:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-172595 |
| 2025-07-0220:15 ET | 8-K | 8.01 Other events | 0001193125-25-154955 |
| 2025-06-1820:31 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-142747 |
| 2025-05-1520:09 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-072619 |
| 2025-05-1520:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-072612 |
| 2025-05-1411:14 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-119386 |
| 2025-04-2920:05 ET | DEF 14A | Proxy statementPeriod 2025-06-17 | 0001193125-25-103763 |
| 2025-03-2712:25 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-045745 |
| 2025-03-2712:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-064729 |
| 2025-03-0321:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-044229 |
| 2025-02-1814:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-028247 |
| 2025-01-1311:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-004909 |
| 2025-01-0612:14 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-001834 |
| 2024-11-2021:17 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-129274 |
| 2024-11-2021:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-262539 |
| 2024-11-0421:39 ET | SC 13D | Ownership report, active investor | 0001104659-24-113930 |
| 2024-10-2820:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-245578 |
| 2024-10-2411:51 ET | S-1/A | Registration statement, amended | 0001193125-24-242300 |
| 2024-10-2110:11 ET | S-1/A | Registration statement, amended | 0001193125-24-239994 |
| 2024-10-0220:22 ET | S-1 | Registration statement | 0001193125-24-231178 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.